As of Jun 22
| +0.40 / +6.50%|
The 2 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 25.00, with a high estimate of 40.00 and a low estimate of 10.00. The median estimate represents a +281.68% increase from the last price of 6.55.
The current consensus among 2 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.